Anita Kazdepka-Ziemińska

Anita Kazdepka-Ziemińska

Auto-generated profile, based on publicly available information

Anita Kazdepka-Ziemińska

Department of Perinatology, Gynecology and Gynecologic Oncology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Łukasiewicza 1, 85-821 Bydgoszcz, Poland

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
Maciej W. SochaMaciej W. Socha
Maciej W. Socha
WFWojciech Flis
Wojciech Flis
Mateusz WartęgaMateusz Wartęga
Mateusz Wartęga
MSMonika Szambelan
Monika Szambelan
MPMiłosz Pietrus
Miłosz Pietrus
AKAnita Kazdepka-Ziemińska
Anita Kazdepka-Ziemińska
The gestational period is an incredibly stressful time for a pregnant woman. Pregnant patients constantly seek effective and reliable compounds in order to achieve a healthy labor. Nowadays, increasing numbers of women use herbal preparations and supplements during pregnancy. One of the most popular and most frequently chosen herbs during pregnancy is the raspberry leaf (Rubus idaeus). Raspberry extracts are allegedly associated with a positive effect on childbirth through the induction of uterine contractions, acceleration of the cervical ripening, and shortening of childbirth. The history of the consumption of raspberry leaves throughout pregnancy is vast. This review shows the current status of the use of raspberry leaves in pregnancy, emphasizing the effect on the cervix, and the safety profile of this herb. The majority of women apply raspberry leaves during pregnancy to induce and ease labor. However, it has not been possible to determine the exact effect of using raspberry extracts on the course of childbirth and the perinatal period. Additionally, it is unclear whether this herb has only positive effects. The currently available data indicate a weak effect of raspberry leaf extracts on labor induction and, at the same time, their possible negative impact on cervical ripening.

1 January 2015 in Ginekologia Polska
Verified
Journal Article
Open access
IJIwona Jagielska
Iwona Jagielska
AKAnita Kazdepka-Ziemińska
Anita Kazdepka-Ziemińska
AKAnita Kaczorowska
Anita Kaczorowska
AMAnna Madej
Anna Madej
TKTomasz Kolossa
Tomasz Kolossa
MGMarek Grabiec
Marek Grabiec
Objectives: Evaluation of carbetocin and oxytocin efficiency in preventive treatment of PPH after cesarean section. Material and methods: The research included 130 female patients after C-section who obtained 100 µg of carbetocin i.v. as a preventive agent after the surgery. The control...

14 December 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Maciej W. SochaMaciej W. Socha
Maciej W. Socha
WFWojciech Flis
Wojciech Flis
JSJulia Sowińska
Julia Sowińska
MSMartyna Stankiewicz
Martyna Stankiewicz
AKAnita Kazdepka-Ziemińska
Anita Kazdepka-Ziemińska
Background: Maternal obesity may influence the efficacy and course of induction of labor (IoL). Misoprostol, a prostaglandin E1 analogue, is widely used for cervical ripening, but evidence regarding its effectiveness in obese women remains limited. This study aimed to evaluate the efficacy and safety of oral misoprostol for IoL across different body mass index (BMI) categories. Methods: This prospective study was conducted at a tertiary center. Term singleton pregnancies with medical indications for IoL and an unfavorable cervix (Bishop score < 6) received oral misoprostol 50 μg every 4 h to a maximum of 200 μg. Primary outcomes were vaginal delivery (VD) rates. Secondary outcomes included cesarean section (CS) rate, oxytocin use, labor duration, analgesia, adverse events, and neonatal outcomes. Results: Among 291 participants (43.0% overweight; 40.2% obese), the Bishop score increased from 2.3 to 6.2 (p < 0.0001). VD occurred in 77.3%, and CS in 22.7%. Most women delivered within 48 h (96.6%). Higher BMI correlated with longer time to contractions, pain onset, and delivery, as well as with more misoprostol doses. Neonatal outcomes were uniformly favorable, with median Apgar scores of 10 at 1, 5, and 10 min, and mean umbilical pH values ranging from 7.2 to 7.3. Adverse events were infrequent, with tachysystole observed in 1.7% of cases. Conclusions: Oral misoprostol is an effective and safe IoL method across BMI categories, achieving high vaginal delivery rates and favorable neonatal outcomes. Obesity modestly prolongs induction and increases dose requirements, supporting individualized dosing and close monitoring.